• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病原体驱动的 CRISPR 筛选鉴定 TREX1 为流感病毒感染期间 DNA 自我感知的调节剂。

Pathogen-driven CRISPR screens identify TREX1 as a regulator of DNA self-sensing during influenza virus infection.

机构信息

Department of Medical Microbiology & Immunology, University of Wisconsin-Madison, Madison, WI 53706, USA.

Department of Pediatrics, University of Wisconsin-Madison, Madison, WI 53706, USA.

出版信息

Cell Host Microbe. 2023 Sep 13;31(9):1552-1567.e8. doi: 10.1016/j.chom.2023.08.001. Epub 2023 Aug 30.

DOI:10.1016/j.chom.2023.08.001
PMID:37652009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10528757/
Abstract

Host:pathogen interactions dictate the outcome of infection, yet the limitations of current approaches leave large regions of this interface unexplored. Here, we develop a novel fitness-based screen that queries factors important during the middle to late stages of infection. This is achieved by engineering influenza virus to direct the screen by programming dCas9 to modulate host gene expression. Our genome-wide screen for pro-viral factors identifies the cytoplasmic DNA exonuclease TREX1. TREX1 degrades cytoplasmic DNA to prevent inappropriate innate immune activation by self-DNA. We reveal that this same process aids influenza virus replication. Infection triggers release of mitochondrial DNA into the cytoplasm, activating antiviral signaling via cGAS and STING. TREX1 metabolizes the DNA, preventing its sensing. Collectively, these data show that self-DNA is deployed to amplify innate immunity, a process tempered by TREX1. Moreover, they demonstrate the power and generality of pathogen-driven fitness-based screens to pinpoint key host regulators of infection.

摘要

宿主-病原体相互作用决定了感染的结果,但目前的方法存在局限性,使得这一界面的很大一部分未被探索。在这里,我们开发了一种新颖的基于适应性的筛选方法,用于研究感染中后期重要的因素。通过工程化流感病毒,我们实现了这一目标,通过编程 dCas9 来调节宿主基因表达,从而引导筛选。我们进行了全基因组筛选以寻找促进病毒的因素,发现了细胞质 DNA 外切酶 TREX1。TREX1 降解细胞质 DNA,防止自身 DNA 引起不适当的先天免疫激活。我们揭示了这个相同的过程有助于流感病毒的复制。感染触发线粒体 DNA 释放到细胞质中,通过 cGAS 和 STING 激活抗病毒信号。TREX1 代谢 DNA,防止其被感知。总的来说,这些数据表明,自身 DNA 被用来放大先天免疫,而 TREX1 则对其进行了调节。此外,它们还展示了病原体驱动的适应性筛选在确定感染关键宿主调节剂方面的强大功能和通用性。

相似文献

1
Pathogen-driven CRISPR screens identify TREX1 as a regulator of DNA self-sensing during influenza virus infection.病原体驱动的 CRISPR 筛选鉴定 TREX1 为流感病毒感染期间 DNA 自我感知的调节剂。
Cell Host Microbe. 2023 Sep 13;31(9):1552-1567.e8. doi: 10.1016/j.chom.2023.08.001. Epub 2023 Aug 30.
2
Pathogen-driven CRISPR screens identify TREX1 as a regulator of DNA self-sensing during influenza virus infection.病原体驱动的CRISPR筛选确定TREX1是流感病毒感染期间DNA自我感知的调节因子。
bioRxiv. 2023 Feb 7:2023.02.07.527556. doi: 10.1101/2023.02.07.527556.
3
Systematic review and meta-analysis of genome-wide pooled CRISPR screens to identify host factors involved in influenza A virus infection.系统评价和荟萃分析全基因组 CRISPR 筛选以鉴定参与甲型流感病毒感染的宿主因素。
J Virol. 2024 May 14;98(5):e0185723. doi: 10.1128/jvi.01857-23. Epub 2024 Apr 3.
4
HIV-1 Activation of Innate Immunity Depends Strongly on the Intracellular Level of TREX1 and Sensing of Incomplete Reverse Transcription Products.HIV-1 激活先天免疫强烈依赖于 TREX1 的细胞内水平和对不完全逆转录产物的感应。
J Virol. 2018 Jul 31;92(16). doi: 10.1128/JVI.00001-18. Print 2018 Aug 15.
5
Human Three Prime Repair Exonuclease 1 Promotes HIV-1 Integration by Preferentially Degrading Unprocessed Viral DNA.人源 3' 端修复外切酶 1 通过优先降解未加工的病毒 DNA 促进 HIV-1 整合。
J Virol. 2021 Aug 10;95(17):e0055521. doi: 10.1128/JVI.00555-21.
6
The Exonuclease TREX1 Constitutes an Innate Immune Checkpoint Limiting cGAS/STING-Mediated Antitumor Immunity.核酸外切酶 TREX1 构成先天免疫检查点,限制 cGAS/STING 介导体抗肿瘤免疫。
Cancer Immunol Res. 2024 Jun 4;12(6):663-672. doi: 10.1158/2326-6066.CIR-23-1078.
7
Mutations in the non-catalytic polyproline motif destabilize TREX1 and amplify cGAS-STING signaling.非催化多脯氨酸基序中的突变会使 TREX1 不稳定,并放大 cGAS-STING 信号。
Hum Mol Genet. 2024 Sep 3;33(18):1555-1566. doi: 10.1093/hmg/ddae089.
8
cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing.cGAS 液-液相分离抑制 TREX1 介导的 DNA 降解并增强细胞质 DNA 感应。
Mol Cell. 2021 Feb 18;81(4):739-755.e7. doi: 10.1016/j.molcel.2021.01.024.
9
TREX1 as a Novel Immunotherapeutic Target.TREX1 作为一种新型免疫治疗靶标。
Front Immunol. 2021 Apr 1;12:660184. doi: 10.3389/fimmu.2021.660184. eCollection 2021.
10
Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection.全基因组 CRISPR 筛选鉴定流感 A 病毒感染的宿主依赖性因素。
Nat Commun. 2020 Jan 9;11(1):164. doi: 10.1038/s41467-019-13965-x.

引用本文的文献

1
Advancements in CRISPR/Cas systems for disease treatment.用于疾病治疗的CRISPR/Cas系统的进展。
Acta Pharm Sin B. 2025 Jun;15(6):2818-2844. doi: 10.1016/j.apsb.2025.05.007. Epub 2025 May 17.
2
SARS-CoV-2 infection induces ZBP1-dependent PANoptosis in bystander cells.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染在旁观者细胞中诱导依赖于ZBP1的全程序坏死性凋亡。
Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2500208122. doi: 10.1073/pnas.2500208122. Epub 2025 Jul 8.
3
The impact of C heavy ion irradiation-induced cellular mutations on the replication of the foot-and-mouth disease virus and the role of Cbr3.碳重离子辐照诱导的细胞突变对口蹄疫病毒复制的影响及Cbr3的作用
Cell Mol Life Sci. 2025 Jun 28;82(1):261. doi: 10.1007/s00018-025-05628-6.
4
IFIT3 RNA-binding activity promotes influenza A virus infection and translation efficiency.IFIT3的RNA结合活性促进甲型流感病毒感染及翻译效率。
J Virol. 2025 Jul 22;99(7):e0028625. doi: 10.1128/jvi.00286-25. Epub 2025 Jun 11.
5
NEIL1 block IFN-β production and enhance vRNP function to facilitate influenza A virus proliferation.NEIL1可阻断干扰素-β的产生并增强病毒核糖核蛋白(vRNP)功能,以促进甲型流感病毒增殖。
Npj Viruses. 2024 Nov 21;2(1):57. doi: 10.1038/s44298-024-00065-x.
6
Deep mutational scanning and CRISPR-engineered viruses: tools for evolutionary and functional genomics studies.深度突变扫描与CRISPR工程病毒:用于进化与功能基因组学研究的工具
mSphere. 2025 May 27;10(5):e0050824. doi: 10.1128/msphere.00508-24. Epub 2025 Apr 24.
7
Influenza virus antagonizes self sensing by RIG-I to enhance viral replication.流感病毒通过拮抗维甲酸诱导基因I(RIG-I)的自身感应来增强病毒复制。
bioRxiv. 2025 Mar 12:2025.03.12.642847. doi: 10.1101/2025.03.12.642847.
8
Cellular SLC35B4 promotes internalization during influenza A virus entry.细胞溶质载体家族35成员B4(SLC35B4)在甲型流感病毒进入过程中促进内化。
mBio. 2025 May 14;16(5):e0019425. doi: 10.1128/mbio.00194-25. Epub 2025 Mar 25.
9
Cytosolic nucleic acid sensing as driver of critical illness: mechanisms and advances in therapy.胞质核酸感应作为危重症的驱动因素:机制与治疗进展
Signal Transduct Target Ther. 2025 Mar 19;10(1):90. doi: 10.1038/s41392-025-02174-2.
10
IFIT3 RNA-binding activity promotes influenza A virus infection and translation efficiency.IFIT3的RNA结合活性促进甲型流感病毒感染及翻译效率。
bioRxiv. 2025 Apr 12:2025.02.17.638785. doi: 10.1101/2025.02.17.638785.

本文引用的文献

1
Alternative splicing liberates a cryptic cytoplasmic isoform of mitochondrial MECR that antagonizes influenza virus.可变剪接使线粒体 MECR 的一个隐藏的细胞质异构体得以释放,该异构体拮抗流感病毒。
PLoS Biol. 2022 Dec 21;20(12):e3001934. doi: 10.1371/journal.pbio.3001934. eCollection 2022 Dec.
2
Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection.B3GAT1 通过细胞糖基化修饰广泛限制流感病毒感染。
Nat Commun. 2022 Oct 29;13(1):6456. doi: 10.1038/s41467-022-34111-0.
3
Retasking of canonical antiviral factors into proviral effectors.将经典抗病毒因子重新分配为病毒前体效应物。
Curr Opin Virol. 2022 Oct;56:101271. doi: 10.1016/j.coviro.2022.101271. Epub 2022 Oct 13.
4
Influenza A virus undergoes compartmentalized replication in vivo dominated by stochastic bottlenecks.甲型流感病毒在体内进行分隔复制,主要受随机瓶颈的控制。
Nat Commun. 2022 Jun 14;13(1):3416. doi: 10.1038/s41467-022-31147-0.
5
A Programmable In Vivo CRISPR Activation Model Elucidates the Oncogenic and Immunosuppressive Functions of MYC in Lung Adenocarcinoma.可编程体内 CRISPR 激活模型阐明了 MYC 在肺腺癌中的致癌和免疫抑制功能。
Cancer Res. 2022 Aug 3;82(15):2761-2776. doi: 10.1158/0008-5472.CAN-21-4009.
6
The cGAS-STING pathway drives type I IFN immunopathology in COVID-19.cGAS-STING 通路驱动 COVID-19 中的 I 型 IFN 免疫病理学。
Nature. 2022 Mar;603(7899):145-151. doi: 10.1038/s41586-022-04421-w. Epub 2022 Jan 19.
7
From high-throughput to therapeutic: host-directed interventions against influenza viruses.从高通量到治疗:针对流感病毒的宿主定向干预措施。
Curr Opin Virol. 2022 Apr;53:101198. doi: 10.1016/j.coviro.2021.12.014. Epub 2022 Jan 11.
8
A genome-wide CRISPR/Cas9 gene knockout screen identifies immunoglobulin superfamily DCC subclass member 4 as a key host factor that promotes influenza virus endocytosis.全基因组 CRISPR/Cas9 基因敲除筛选发现免疫球蛋白超家族 DCC 亚类成员 4 是促进流感病毒内吞作用的关键宿主因子。
PLoS Pathog. 2021 Dec 6;17(12):e1010141. doi: 10.1371/journal.ppat.1010141. eCollection 2021 Dec.
9
The type I interferonopathies: 10 years on.Ⅰ型干扰素病:10 年进展。
Nat Rev Immunol. 2022 Aug;22(8):471-483. doi: 10.1038/s41577-021-00633-9. Epub 2021 Oct 20.
10
Pharmacological activation of STING blocks SARS-CoV-2 infection.STING 的药理学激活可阻断 SARS-CoV-2 感染。
Sci Immunol. 2021 May 18;6(59). doi: 10.1126/sciimmunol.abi9007.